This report shows public data only. Is this your organisation? If so, login here to view your full report.

CDC International Capital

PRI reporting framework 2018

You are in Direct - Fixed Income » ESG incorporation in actively managed fixed income » Implementation processes

Implementation processes

FI 01. Incorporation strategies applied

01.1. Indicate 1) Which ESG incorporation strategy and/or combination of strategies you apply to your actively managed fixed income investments; and 2) The proportion (+/- 5%) of your total actively managed fixed income investments each strategy applies to.

Corporate (non-financial)
0 Screening alone
0 Thematic alone
0 Integration alone
100 Screening + integration strategies
0 Thematic + integration strategies
0 Screening + thematic strategies
0 All three strategies combined
0 No incorporation strategies applied

01.2. Describe your reasons for choosing a particular ESG incorporation strategy and how combinations of strategies are used.

CDC International Capital considers that taking into account environmental, social and governance (ESG) issues in its investment policy contributes to the sustainability of its investments and of the economy and society at large.

The responsible investment policy of CDC International Capital combines several approaches that are tailored to each asset type:

- Mainstream / general approach i.e. ESG incorporation: integration of ESG issues in all the investment stages, from the preinvestment stage, through the holding period to the end of the investment.

- Negative screening : Overall compliance of the operation with the anti-money laundering and terrorist financing rules, mainly in order to check compliance issues (compliance of the operation with the anti-money laundering and terrorist financing rules, respect of environmental and social standards recognised by the French and European legislation, compliance with international treaties and laws, etc.) but also restriction of the investment's universe, in particular if the asset's activity is not suitable with general interest or if any improvement won't be possible.

01.3. Additional information [Optional].

FI 02. ESG issues and issuer research (Private)

FI 03. Processes to ensure analysis is robust

03.1. Indicate how you ensure that your ESG research process is robust:

specify description

          CDC IC works closely with an external ESG consultant to crosscheck the accuracy and relevance of its ESG process.

03.2. Describe how your ESG information or analysis is shared among your investment team.

          The new ESG process formalised in 2017 states that ESG information (i.e. identification of ESG issues, etc.) are included within the investment note.

03.3. Additional information. [Optional]